
MediWound
(NASDAQ) MDWD
MediWound Financials at a Glance
Market Cap
$182.15M
Revenue (TTM)
$14.48M
Net Income (TTM)
-$26.11M
EPS (TTM)
-$2.26
P/E Ratio
-6.28
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$14.19
Volume
1,608
Open
$14.41
Price
$14.19
Volume
1,608
Open
$14.41
Previous Close
$14.19
Daily Range
$14.19 - $14.74
52-Week Range
$13.54 - $21.99
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$14.19
Volume
1,608
Open
$14.41
Previous Close
$14.19
Daily Range
$14.19 - $14.74
52-Week Range
$13.54 - $21.99
Estimated Earnings Date
Aug 13, 2026
MDWD News
MDWD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MediWound
Industry
Pharmaceuticals
Sector
Health CareEmployees
121
CEO
Ofer Gonen
Website
www.mediwound.comHeadquarters
Yavne, 8122745, IL
MDWD Financials
Key Financial Metrics (TTM)
Gross Margin
20%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-72%
Return on Capital
-48%
Return on Assets
-33%
Earnings Yield
-15.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$182.15M
Shares Outstanding
12.85M
Volume
1.61K
Avg. Volume
92.08K
Financials (TTM)
Gross Profit
$3.25M
Operating Income
-$25.28M
EBITDA
-$21.47M
Operating Cash Flow
-$14.53M
Capital Expenditure
-$5.51M
Free Cash Flow
-$20.04M
Cash & ST Invst.
$53.14M
Total Debt
$8.77M
MediWound Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.48M
-62.7%
Gross Profit
$323.00K
-56.2%
Gross Margin
21.90%
N/A
Market Cap
$182.15M
N/A
Market Cap/Employee
$1.64M
N/A
Employees
111
N/A
Net Income
-$2.95M
-306.6%
EBITDA
-$7.60M
-56.2%
Quarterly Fundamentals
Net Cash
$36.52M
+14.7%
Accounts Receivable
$2.75M
-46.9%
Inventory
$4.77M
+33.3%
Long Term Debt
$8.13M
+26.5%
Short Term Debt
$929.00K
N/A
Return on Assets
-32.64%
N/A
Return on Invested Capital
-48.06%
N/A
Free Cash Flow
-$8.57M
-69.1%
Operating Cash Flow
-$6.75M
-64.3%

